Ardent Health Partners, LLC (ARDT) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
ARDT representa a Ardent Health Partners, LLC, una empresa del sector Healthcare con un precio de $8.78 (capitalización de mercado 2B). La acción obtiene una puntuación de 54/100, una calificación moderada basada en 9 KPI cuantitativos.
Ultimo analisis: 8 feb 2026Ardent Health Partners, LLC (ARDT) Resumen de Asistencia Médica y Tuberías
Ardent Health Partners offers a notable research candidate within the healthcare sector, leveraging its established network of hospitals and clinics, strategic focus on diverse healthcare services, and a current P/E ratio of 6.13, positioning it for potential growth and value creation.
Tesis de Inversión
Ardent Health Partners presents a notable research candidate due to its established network of hospitals and clinics, coupled with a focus on diverse healthcare services. With a current P/E ratio of 6.13 and a profit margin of 3.2%, Ardent demonstrates potential for value creation. Key growth catalysts include expanding its network of facilities and enhancing service offerings to capture a larger share of the healthcare market. The company's strong gross margin of 70.6% indicates efficient operations and pricing power. Furthermore, Ardent's beta of 0.71 suggests lower volatility compared to the broader market, making it a noteworthy option for risk-averse investors. The increasing demand for healthcare services, driven by an aging population and advancements in medical technology, provides a favorable backdrop for Ardent's continued growth and profitability. Investors may want to evaluate Ardent for its stability, growth potential, and attractive valuation metrics.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Market capitalization of $1.28 billion reflects Ardent's significant presence in the healthcare market.
- P/E ratio of 6.13 indicates a potentially undervalued stock compared to its earnings.
- Profit margin of 3.2% demonstrates the company's ability to generate profit from its revenue.
- Gross margin of 70.6% highlights efficient cost management and strong pricing power.
- Beta of 0.71 suggests lower volatility compared to the overall market, making it a relatively stable investment.
Competidores y Pares
Fortalezas
- Established network of hospitals and clinics.
- Comprehensive range of healthcare services.
- Strong gross margin of 70.6%.
- Experienced management team.
Debilidades
- Reliance on third-party payers (insurance companies).
- Exposure to regulatory changes in the healthcare industry.
- Potential for increased competition in certain markets.
- Subsidiary status might limit strategic flexibility.
Catalizadores
- Ongoing: Expansion of service offerings to include more specialized medical programs.
- Upcoming: Potential acquisitions of smaller healthcare providers to expand market reach.
- Ongoing: Implementation of technology solutions to improve patient care and operational efficiency.
- Ongoing: Strategic partnerships with insurance companies to enhance patient access.
Riesgos
- Potential: Changes in government healthcare policy could negatively impact reimbursement rates.
- Ongoing: Rising operating costs, including labor and supplies, could erode profit margins.
- Ongoing: Increased competition from other healthcare providers could lead to pricing pressure.
- Potential: Medical malpractice claims could result in significant financial liabilities.
- Potential: Economic downturn could reduce patient volumes and revenue.
Oportunidades de crecimiento
- Expanding Network of Facilities: Ardent has the opportunity to grow by acquiring or developing new hospitals and clinics in underserved markets. The U.S. healthcare market is projected to reach $6.2 trillion by 2028, providing ample opportunity for expansion. By strategically targeting areas with growing populations and limited access to healthcare services, Ardent can increase its market share and revenue. This expansion could be achieved through strategic partnerships or acquisitions, with a timeline of 3-5 years.
- Enhancing Service Offerings: Ardent can enhance its service offerings by investing in specialized medical programs, such as cardiology, oncology, and orthopedics. The market for specialized medical services is growing rapidly, driven by advancements in medical technology and increasing demand from patients. By offering a wider range of specialized services, Ardent can attract more patients and increase its revenue per patient. This enhancement can be implemented within 2-3 years.
- Improving Operational Efficiency: Ardent can improve its operational efficiency by implementing lean management principles and investing in technology to streamline processes and reduce costs. The healthcare industry is facing increasing pressure to reduce costs while maintaining quality of care. By improving operational efficiency, Ardent can increase its profit margins and remain competitive. This improvement can be achieved through process optimization and technology adoption within 1-2 years.
- Leveraging Technology: Ardent can leverage technology to improve patient care, enhance operational efficiency, and expand its reach. Telemedicine, remote patient monitoring, and data analytics are transforming the healthcare industry, offering new opportunities for providers to deliver care more efficiently and effectively. By embracing these technologies, Ardent can improve patient outcomes, reduce costs, and gain a competitive advantage. Implementation can start immediately and scale over 2-5 years.
- Strategic Partnerships: Ardent can form strategic partnerships with other healthcare providers, insurance companies, and technology companies to expand its reach and enhance its service offerings. Collaboration is becoming increasingly important in the healthcare industry, as providers seek to deliver more integrated and coordinated care. By forming strategic partnerships, Ardent can access new markets, technologies, and expertise, driving growth and innovation. These partnerships can be established within 1-3 years.
Oportunidades
- Expansion into new geographic markets.
- Acquisition of smaller healthcare providers.
- Development of new specialized medical programs.
- Leveraging technology to improve patient care and efficiency.
Amenazas
- Changes in government healthcare policy.
- Rising operating costs (labor, supplies).
- Increased competition from other healthcare providers.
- Potential for medical malpractice claims.
Ventajas competitivas
- Established network of hospitals and clinics provides a geographic advantage.
- Strong relationships with insurance providers ensure a steady stream of patients.
- Reputation for quality care attracts patients and physicians.
- Economies of scale in purchasing and operations reduce costs.
Acerca de ARDT
Founded in 2001 and headquartered in Brentwood, Tennessee, Ardent Health Partners, LLC has established itself as a significant player in the healthcare industry. The company owns and operates a network of hospitals and clinics throughout the United States, providing a comprehensive suite of healthcare services. These services encompass acute care, rehabilitation hospitals, and surgical hospitals, catering to a diverse range of patient needs. Ardent's commitment to quality care and operational efficiency has enabled it to build a strong reputation within the communities it serves. As a subsidiary of EGI-AM Investments, L.L.C., Ardent benefits from strategic guidance and financial support, fostering continued growth and expansion. The company's network is designed to offer accessible and integrated healthcare, ensuring patients receive the right care at the right time. Ardent's focus on patient-centered care, combined with its strategic investments in technology and infrastructure, positions it favorably in the evolving healthcare landscape. The company's dedication to providing a continuum of care, from acute interventions to rehabilitative services, underscores its commitment to improving patient outcomes and enhancing the overall healthcare experience.
Qué hacen
- Operates a network of acute care hospitals.
- Provides rehabilitation hospital services.
- Offers surgical hospital services.
- Manages a network of clinics.
- Delivers a range of healthcare services in the United States.
- Focuses on patient-centered care.
- Provides integrated healthcare solutions.
Modelo de Negocio
- Generates revenue through patient services at hospitals and clinics.
- Receives payments from insurance companies, government programs (Medicare/Medicaid), and self-paying patients.
- Focuses on managing costs and improving operational efficiency to maximize profitability.
Contexto de la Industria
Ardent Health Partners operates within the medical care facilities industry, a sector experiencing steady growth driven by an aging population and increasing demand for healthcare services. The industry is characterized by a mix of large hospital systems and smaller, specialized clinics. Ardent competes with other for-profit and non-profit healthcare providers, including ACHC, ADUS, ASTH, AVAH, and BKD. The market is also influenced by regulatory changes, technological advancements, and evolving patient preferences. Companies that can adapt to these changes and deliver high-quality, cost-effective care are well-positioned for success. Ardent's focus on integrated healthcare services and strategic expansion efforts align with these industry trends.
Clientes Clave
- Individuals seeking acute care services.
- Patients requiring rehabilitation services.
- Individuals in need of surgical procedures.
- Patients seeking general medical care at clinics.
Finanzas
Gráfico e información
Precio de la acción de Ardent Health Partners, LLC (ARDT): $8.78 (+0.30, +3.47%)
Últimas noticias
-
Auna's Mexico Operations Stabilize in Q4: How the Path Ahead Looks
Zacks · 12 mar 2026
-
Earnings Scheduled For March 4, 2026
benzinga · 4 mar 2026
-
Ardent Health Announces Fourth Quarter and Full Year 2025 Results Conference Call and Webcast Date
Yahoo! Finance: ARDT News · 12 feb 2026
-
Avantor, Inc. (AVTR) Surpasses Q4 Earnings and Revenue Estimates
Yahoo! Finance: ARDT News · 11 feb 2026
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para ARDT.
Objetivos de Precios
Objetivo de consenso: $13.07
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de ARDT en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Competidores y Pares
Últimas Noticias
Auna's Mexico Operations Stabilize in Q4: How the Path Ahead Looks
Earnings Scheduled For March 4, 2026
Ardent Health Announces Fourth Quarter and Full Year 2025 Results Conference Call and Webcast Date
Avantor, Inc. (AVTR) Surpasses Q4 Earnings and Revenue Estimates
Último análisis de Ardent Health Partners, LLC
IWM Jumps 1.32% Amid Western Digital's $4B Buyback Plan
2 min de lecturaArdent Health (ARDT) Faces Scrutiny Amid Accounting Allegations; Stock Up 1.27%
2 min de lecturaSecurities Lawsuits Hit ARDT (+4.18%) and RR (-6.57%) Amidst Market Uncertainty
2 min de lecturaLawsuit News Weighs on Stocks: CRWV Up 7.60% Amidst Broader Market Gains
2 min de lecturaMarket Momentum Continues: SPY Up 1.92% Amidst Lawsuit Alerts for ARDT, CPNG, and FFIV
2 min de lecturaLo Que los Inversores Preguntan Sobre Ardent Health Partners, LLC (ARDT)
¿Cuáles son los factores clave para evaluar ARDT?
Ardent Health Partners, LLC (ARDT) actualmente tiene una puntuación IA de 54/100, indicando puntuación moderada. La acción cotiza a un P/E de 7.3x, por debajo del promedio del S&P 500 (~20-25x), potencialmente señalando valor. Los analistas apuntan a $13.07 (+49% desde $8.78). Fortaleza clave: Established network of hospitals and clinics.. Riesgo principal a monitorear: Potential: Changes in government healthcare policy could negatively impact reimbursement rates.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de ARDT?
ARDT actualmente puntúa 54/100 (Grado C) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de ARDT?
Los precios de ARDT se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre ARDT?
Los analistas han establecido un precio objetivo de consenso de $13.07 para ARDT, representando un potencial alcista del 49% desde el precio actual de $8.78. La cobertura incluye calificaciones de compra, mantener y venta, estimaciones de ganancias y recientes mejoras o rebajas. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en ARDT?
Las categorías de riesgo para ARDT incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Changes in government healthcare policy could negatively impact reimbursement rates.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de ARDT?
Ardent Health Partners, LLC (ARDT) tiene una relación P/E de 7.3, que está por debajo del promedio del mercado, lo que puede sugerir valor relativo. La relación P/E compara el precio de la acción con sus ganancias por acción. Compare con el promedio del S&P 500 (~20-25x) para contexto. Esto no es asesoramiento financiero.
¿Está ARDT sobrevalorada o infravalorada?
Determinar si Ardent Health Partners, LLC (ARDT) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Su relación P/E es 7.3. Objetivo de analistas $13.07 (+49% desde el precio actual). Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de ARDT?
Ardent Health Partners, LLC (ARDT) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Financial data is based on available information and may be subject to change.
- Industry analysis is based on current market trends and may not reflect future developments.
- Investment decisions should be made based on individual circumstances and consultation with a financial advisor.